Dipyridamole
Splenectomy; Status
Northern Jiangsu People's HospitalSmall moleculePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 53/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Splenectomy; Status cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Apixaban Northern Jiangsu People's Hospital | Phase 4 | BB |
ZINC SULFATE Fakultas Kedokteran Universitas Indonesia | Phase 4 | BB |
Acetylsalicylic Acid Northern Jiangsu People's Hospital | Phase 4 | BB |
WARFARIN Northern Jiangsu People's Hospital | Phase 4 | BB |
Hydroxyurea Fakultas Kedokteran Universitas Indonesia | Phase 4 | BB |
Folic Acid Fakultas Kedokteran Universitas Indonesia | Phase 4 | BB |
Same molecule, other indications
Dipyridamole is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →